rost &Sullivan Honors Biophan Technologies for its Nanomagnetic Coating via COMTEX
March 25, 2004
SAN FRANCISCO, Mar 25, 2004 (BUSINESS WIRE) --
Frost &Sullivan recognized Biophan Technologies Inc. (OTCBB:BIPH) with the 2004 Excellence in Medical Imaging Technology of the Year Award at last night`s Global Excellence in Medical Devices Awards Banquet.
Frost &Sullivan presents the Excellence in Medical Imaging Technology of the Year Award to the company that has pioneered the development and introduction of an innovative product that has brought about a significant shift in market adoption, initiation of a new trend, and eventually, a change in the competitive landscape.
Biophan`s nanoparticle-based biomedical coating significantly reduces tissue damage, interference in image quality, and other problems caused by medical implants during magnetic resonance imaging (MRI) scan, greatly benefiting patients using medical implants such as cardiac pacemakers.
Nanomagnetic coating shields the strong electromagnetic (EM) radio waves that are generated when the EM fields created during MRI scan interact with interventional and implanted medical devices. Without such shielding, the EM fields could induce high current to heat the metal implants and damage tissues surrounding them, which could prove fatal. Effectively, this novel coating has made medical implants `MRI-safe.`
Other medical devices such as guide wires, catheter, and endoscopes can also utilize nanomagnetic coatings for shielding. The benefits of real-time MRI can be realized with the application of nano-coated guide wires in surgical procedures. Additionally, these coatings are useful in creating an MRI signal that would otherwise be invisible to MR imaging.
In addition to coating capabilities, these nanomaterials can also be employed as MRI contrast agents that highlight specific tissues that may be infected or malfunctioning. The materials assist in enhancing the accuracy of diagnosis for different types of cancers and genetic abnormalities.
Biophan`s uniqueness lies in its ability to offer customized nanomagnetic coatings based on end users`need and application.
`Uniquely, Biophan seeks to position itself as a service provider to other prominent partners in the medical devices sector rather than manufacturing medical devices itself,`notes Giridhar Rao, industry analyst with Frost &Sullivan. `Biophan`s commitment toward research and development is clearly evident from the fact that it already possesses four issued patents and has more than 50 pending clearance. These developments indicate the potential and attractiveness of Biophan`s technology to other medical technology providers,`Rao adds.
Held in San Francisco, the Frost &Sullivan banquet honored world-class companies for outstanding performance and achievements in the medical devices segment. An annual event, the banquet recognizes the quality and merit of distinguished individuals and companies.
About Biophan Technologies Inc.
Located in West Henrietta, N.Y., Biophan develops and markets cutting-edge technologies that are used while manufacturing biomedical devices such as cardiac pacemakers, and surgical and diagnostic tools. Particularly, its latest offering -- nanomagnetic coating -- has immensely enhanced the safety of MRI scans. Committed to growth through innovation and developmental leadership, Biophan and its licensors have four U.S. patents and over 50 patents pending in high-potential areas including nanomagnetic particle coatings, radio frequency filters, polymer composites, and photonics. Armed with unique technologies and patents, Biophan is well on its way to achieve the goal of making all biomedical devices safe and MRI-compatible. For more information, please visit www.biophan.com.
About Frost &Sullivan
Founded in 1961, Frost &Sullivan is recognized as a global leader in growth consulting. Frost &Sullivan Awards are presented to companies that demonstrate excellence in their industry, commending the diligence, commitment, and innovative business strategies required to advance in the global marketplace. Frost &Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com.
SOURCE: Frost &Sullivan
Frost &Sullivan, San Antonio Jamie Frizzell, 210-247-2496 jfrizzell@frost.com
Customize your Business Wire news &multimedia to match your needs. Get breaking news from companies and organizations worldwide. Logon for FREE today at www.BusinessWire.com.
Copyright (C) 2004 Business Wire. All rights reserved.
Print story
Current Quote
OBB: BIPH Healthcare
Last: 1.150 Change: N/A Volume: N/A Day High: N/A Day Low: N/A
First Alert News Get real-time BIPH release alerts by entering your email address below.
Wahnsinn,hier passiert richtig was.Wartet ab heute gehts richtig ab.Ich habs im Gefühl!KZkurzfristig 2-2,50$
|